Top 50 Health Care VC (Venture Capital) Funds in Finland in October 2023
Top 50 Health Care VC (Venture Capital) Funds in Finland in October 2023
| Investor | Health Care Finland investments |
|---|---|
| Butterfly Ventures | 18 |
| Lifeline Ventures | 17 |
| Finnvera Venture Capital | 15 |
| Tesi | 15 |
| Icebreaker.vc | 11 |
| Voima Ventures | 10 |
| Innovestor | 10 |
| Business Finland | 9 |
| Inventure | 7 |
| Reaktor Ventures | 6 |
| Visionplus | 5 |
| Nidoco | 4 |
| Springvest | 4 |
| VTT Ventures | 4 |
| Oy Hammaren & Co Ab | 4 |
| Cor Group | 3 |
| First Fellow Partners | 3 |
| Sitra | 3 |
| M Ventures | 3 |
| Superhero Capital | 2 |
| Karolinska | 2 |
| Gorilla Capital | 2 |
| Conor Venture Partners | 2 |
| HealthCap | 2 |
| Athensmed | 2 |
| Novartis Venture Fund | 2 |
| European Investment Bank | 2 |
| Pontos Group | 2 |
| Novo Holdings | 2 |
| EQT life science | 2 |
| Nina Capital | 2 |
| Capricorn Partners | 2 |
| Broadview Ventures | 2 |
| Metsola Ventures | 2 |
| Maki.vc | 2 |
| Sofinnova Partners | 2 |
| Vesalius Biocapital Partners | 2 |
| IPF Partners | 1 |
| Spintop Ventures | 1 |
| Emerald Technology Ventures | 1 |
| Loudspring | 1 |
| J12 | 1 |
| Nordic Option | 1 |
| Microsize | 1 |
| Way to Wellville | 1 |
| Gerresheimer Glas | 1 |
| Volvo Cars | 1 |
| Heraeus | 1 |
| Midinvest Management | 1 |
| Blue Ivy Ventures | 1 |
Get 300+ niche investors in 2 minutes.
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Trusted by 21,000+ founders from:
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Health Care, Software, Information Technology
- Seed, Funding Round, Pre-Seed
- Finland, Sweden, Norway
Portfolio highlights
- Reactional Music — GESTRUMENT is the revolutionary gesture based instrument.
- EmbeDL — Efficient Deep Learning for Embedded Systems
- Retein — Aquammodate is a greentech company that produces highly pure water at minimum energy cost.
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more...Investment focus
- Software, Health Care, E-Commerce
- Seed, Series A, Funding Round
- Finland, United States, United Kingdom
Portfolio highlights
- Metroc — Creating sales and marketing solutions for the construction & real-estate industry.
- Measurlabs — We provide testing services for any material, product, or chemical, helping product developers and quality managers get the information they need about their products.
- Steady Energy — Steady Energy aims to decarbonize the energy-intensive heating industry starting with residential and district heating.
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more...Investment focus
- Software, Health Care, Information Technology
- Seed, Funding Round, Series A
- Finland, United States, Switzerland
Portfolio highlights
- Enfuce — Enfuce is a cloud-based financial services provider that specializes in card issuing and payment processing services. It helps banks, fintech, and financial institutions become and remain fully PSD2 compliant, and helps them give third-party service providers access to digital accounts.The company was founded in 2016 and is headquartered inEspoo, Finland.
- Nordcloud — Nordcloud is a European leader in public cloud infrastructure solutions and cloud-native application services. Since 2011 we have completed more than 500 deployments to help our enterprise customers gain the maximum benefits of the cloud, including security, agility, scalability and overall cost-savings.
- Aurealis Pharma — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more...Investment focus
- Software, Manufacturing, Health Care
- Funding Round, Series A, Series B
- Finland, United States, Argentina
Portfolio highlights
- Virta — The Virta platform for electric vehicle charging gives you an accelerated and cost-effective channel to launch, operate, and grow an EV charging business.
- Measurlabs — We provide testing services for any material, product, or chemical, helping product developers and quality managers get the information they need about their products.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Software, Information Technology, Artificial Intelligence
- Pre-Seed, Seed, Series A
- Finland, Estonia, Sweden
Portfolio highlights
- Aibidia — Discover the Aibidia TXM Platform and our digital transfer pricing applications, eliminating billions of euros in tax inefficiencies and risks.
- Fixably — Fixably is the repair management solution to seamlessly connect all users, from the end customer to the technician, and all repair systems within your service business.
- IPRally — Improve your invalidity, patentability and FTO searches. Easy-to-use patent search web application, powered by unique AI knowledge graph technology.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Biotechnology, Health Care, Software
- Seed, Pre-Seed, Funding Round
- Finland, Norway, Sweden
Portfolio highlights
- ÄIO — Innovative food technologies to replace palm oil, coconut oil and animal fats with sustainable and healthier alternatives.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
- Quantagonia — Advanced quantum algorithms, for your most important business problems, delivering breakthrough performance on today's high-performance computers, with seamless migration for later use on quantum computers.
Welcome to Innovestor! We are a Finnish investment company focusing on venture capital, corporate venturing services, and real estate.
Show more...Investment focus
- Software, Health Care, Manufacturing
- Funding Round, Seed, Series A
- Finland, Denmark, Sweden
Portfolio highlights
- SynergyXR — SynergyXR is a no-code, cloud platform that lets companies design, onboard, sell, and support across all XR devices without writing a single line of code
- HVR Cardio — HVR Cardio Transformative Mitral Valve Repair Solutions The Future of Mitral Valve Repair Our mission is to develop solutions for mitral valve interventions that are faster, easier to use, and less invasive without compromising clinical efficacy. About HVR Cardio Utilization of new technologies and less...
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more...Investment focus
- Software, Information Technology, SaaS
- Seed, Grant, Funding Round
- Finland, United States, United Kingdom
Portfolio highlights
- Fixably — Fixably is the repair management solution to seamlessly connect all users, from the end customer to the technician, and all repair systems within your service business.
- Valosan — Scale your international PR into any local market. With Valosan, you connect with PR specialists in local markets and pitch your story to real journalists
- Vensum Power — Revolutionizing power conversion. More power in same package, less energy waste and low maintenance.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Funding Round
- Finland, Sweden, Denmark
Portfolio highlights
- Haltian — End-to-end IoT solutions and world-glass product design services from Haltian
- Commsignia — Commsignia specializes in the research and development, manufacturing and distribution of cooperative intelligent transportation systems. Its product line includes a V2X Communication Software Stack and Commsignia’s own security stack implementation, Hybrid V2X/ADAS Safety Applications, a V2X Simulator, On-Board Units (OBU) and Roadside Units(RSU).The company was founded in 2012 and is headquartered in Santa Clara, California.
- Value.Space — Space based risk assessments & monitoring
Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies.
Show more...Investment focus
- Software, Internet, Health Care
- Seed, Pre-Seed, Series A
- Finland, Germany, United States
Portfolio highlights
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- Swappie — Buy refurbished iPhones at an affordable price - Swappie offers refurbished and cheap iPhones with a free 12-month Swappie warranty.
- Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
WE HELP YOU TO GROW FASTER!
Show more...Investment focus
- Software, Information Technology, Internet
- Seed, Funding Round, Series A
- Finland, United States, United Kingdom
Portfolio highlights
- Pebble — Pebble is a electric vehicle manufacturing startup.
- Transfluent — Professional translations for all business needs. Fast. Easy.
- BetterDoctor — BetterDoctor helps validate and deliver accurate provider data to health plans, health systems, and hundreds of other companies via its API — from startups to publicly traded ones. This ultimately helps achieve the mission of helping consumers find the healthcare they need.Today, BetterDoctor's data platform and APIs power 9 health plans,350 companies, 1,500 developers, helping millions of people find the right doctor each month. Health Plans BetterDoctor uses multi-modal outreach to drive providers to attest their information on BetterDoctor's online portal. API PartnersBetterDoctor brings transparency to doctor data. Their real-time platform, master database and API services enable everyone to add doctor data to their systems, websites and applications. Today, BetterDoctor API and data tools power health insurance companies, healthcare startups and doctor search tools. https://betterdoctor.com/developers
Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies.
Show more...Investment focus
- Health Care, Software, Artificial Intelligence
- Seed, Funding Round, Series B
- Finland, Sweden, Estonia
Portfolio highlights
- Spiral — Easily make a difference every day
- Voltan Energy — Voltan Energy is a sustainable and affordable local heating and cooling solutions.
- Skeleton Technologies — Skeleton Technologies is the global leader in ultracapacitor & supercapacitor energy storage and helps companies in automotive, transportation, grid, and industry to save energy.
Investment focus
- Biotechnology, Health Care, Energy
- Series A, Funding Round
- Finland
Portfolio highlights
- Convion — Convion is a fuel cell system developer committed to commercializing solid oxide fuel cell systems in range of 50–300kW for distributed power generation. The company's products are designed for premium energy efficiency, reliability, and operational flexibility. Convion will provide its customers with sustainable power generation solutions forpower security, energy independence, and premium efficiency.Convion was founded 2012 and is based in Finland.
- Mobidiag — Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company that develops and markets innovative molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management, healthcare associated infections (HAIs), respiratory infections and sepsis. Based on well-established qPCR and microarraytechnologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and markers for antibiotic resistance.
- Finbiosoft — Finbiosoft is a company focused in developing Validation Manager™ software service. Validation Manager is the perfect tool for clinical laboratories and diagnostic companies to digitalize, automate and standardize the time-consuming and error sensitive data handling of validations and verifications.
VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more...Investment focus
- Manufacturing, Biotechnology, 3D Technology
- Seed, Funding Round, Series A
- Finland
Portfolio highlights
- Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
- Quanturi Oy — Quanturi's robust wireless temperature monitoring systems are specifically designed for monitoring hay, compost, grain and many other fermentable materials during storage. Our systems decrease fire risks and ensure quality certification.
- Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Oy Hammaren & Co Ab provides financial services and insurance activities.
Show more...Investment focus
- Health Care, Wellness, GreenTech
- Funding Round, Angel, Series A
- Finland
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- Heltti — We are Heltti. A group of more than +160 experts of knowledge work. We help people and knowledge workplaces feel better.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more...Investment focus
- Health Care, Medical, Biotechnology
- Seed, Pre-Seed, Series A
- Finland
Portfolio highlights
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — Driving the shift from reactive to preventative care with innovative solutions that enable early detection and proactive management of health risks.
A private investment firm run by Risto Siilasmaa and Kim Groop. Grounded in a deeply held set of values around entrepreneurship, trust, integrity and helping solve the world’s problems. We partner with strong and ambitious technology entrepreneurs driven by a mission to fix or build something important in the world.
Show more...Investment focus
- Software, SaaS, Enterprise Software
- Seed, Series A, Funding Round
- Finland, United States, Estonia
Portfolio highlights
- Paebbl — The modular technology from Paebbl may be included in any carbon capture system and is industrially scalable. As a result, Paebbl provides a raw material stream that is carbon-negative, radically altering the economics of preventing carbon from entering our environment.
- NFTPort — Simple & powerful NFT infrastructure and APIs. Mint NFTs, deploy contracts, get multi-chain NFT data and enhanced APIs. Grab your free API Key now: nftport.xyz
- The Upright Project — Upright enables smarter decision-making for investors, companies and governments by quantifying the net impact of companies.
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more...Investment focus
- Health Care, Biotechnology, Therapeutics
- Funding Round, Series A, Series C
- Finland, The Netherlands
Portfolio highlights
- Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
- SET Ventures — Venture capital firm focused broadly on innovative energy generation, distribution storage and efficiency.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Switzerland, United Kingdom
Portfolio highlights
- BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
- Celestial AI — We develop audacious AI computing platforms that elevate performance, energy and economic efficiencies, enabling our customers to rapidly deploy innovations in their AI applications.
- Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Early-stage VC searching for the next Superheroes.
Show more...Investment focus
- Software, Information Technology, Internet
- Seed, Pre-Seed, Series A
- Finland, Estonia, Lithuania
Portfolio highlights
- Phaver — Welcome to the biggest mobile app on Lens Protocol. Access all that Web3 Social has to offer through one easy-to-use app. Engage with your favourite creators, connect your NFT's, earn rewards and more
- Videobot — Grow your business with personalised video funnels that engage your audience with human interaction, capture leads, guide your users, enhance customer satisfaction and increase conversion rate.Short videos have already become dominant across social media platforms. Now, this beloved user experience is available on company websites as well. The applications are vast and varied. Discover how it all works by reserving your own presentation slot.
- Doublepoint — Solving Next-Generation Interactions. Doublepoint provides future computing platforms more intuitive, robust and versatile interactions.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Funding Round, Seed, Series A
- Sweden, Denmark, United States
Portfolio highlights
- Henlez — Henlez is a Danish startup company.
- OssDsign AB — OssDsign was founded in May 2011 by Professor Håkan Engqvist, Dr Thomas Engstrand, Bo Qwarnstrom, Jonas Åberg, Uppsala University AB and other leading clinical, preclinical and materials researchers and engineers. The key people in the company are presented below. OssDsign has in addition developed a network of international experts in ClinicalAffairs, Regulatory and Business Development.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Gorilla Capital is a Finnish venture capital fund investing in early stage companies that apply technology to solve real business problems of today.
Show more...Investment focus
- Software, Information Technology, SaaS
- Pre-Seed, Seed, Series A
- Finland, Estonia, Sweden
Portfolio highlights
- Xiphera — Xiphera is a Finnish company designing hardware-based security solutions using standardised cryptographic algorithms.
- Jungle AI — Jungle uses artificial intelligence to predict component failure, and poor performance in an advanced asset management software.
- Upsy Company — Discover Upsy, the AI-powered online shopping assistant designed to transform your webshop into a sales powerhouse. Boost your conversion rates, improve customer service, and amplify your online sales with Upsy's innovative features today
Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics.
Show more...Investment focus
- Software, Analytics, Semiconductor
- Series A, Series B, Seed
- Finland, United States, Sweden
Portfolio highlights
- TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
- Blackwood Seven | Part of Kantar Group — Attribute, predict and optimize the business outcome of marketing and media plans with Blackwood Seven's Unified Marketing Modeling platform.
- Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Funding Round
- United States, Sweden, France
Portfolio highlights
- Hemab — Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Athensmed Oy
Show more...Investment focus
- Health Care, Medical, mHealth
- Seed, Series A, Funding Round
- Finland
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- VideoVisit — Oiva Health on digipalveluiden asiantuntijayritys, joka palvelee kattavasti sosiaali- ja terveysalan toimijoita.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, Switzerland, United Kingdom
Portfolio highlights
- Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
- Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.
- Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more...Investment focus
- Biotechnology, Health Care, Software
- Debt Financing, Post-IPO Debt, Funding Round
- France, Germany, Ireland
Portfolio highlights
- ROCSYS — Meet the world's first autonomous charging solution for electrical vehicles in public transportation, logistics, material handling, and passenger cars.
- Trucksters — We are a transportation company that focuses on providing long distance FTL trucking service through an innovative relay system based on artificial intelligence. We achieve transit times similar to air transport while reducing the costs of traditional road transportation.
- Masdar Capital — Masdar Capital is developing & deploying commercial-scale renewable energy projects.
Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more...Investment focus
- Genetics, Hospital, Automotive
- Funding Round
- Finland
Portfolio highlights
- Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
- Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- United States, Denmark, United Kingdom
Portfolio highlights
- AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
- Octave — Octave is a national behavioral health practice that’s creating a new standard for care delivery that’s both high-quality and accessible to more people. With in-person and virtual clinics in California and New York, the company offers personalized care plans that can include individual therapy, couples therapy, and groups, while pioneeringrelationships with payers to make care more affordable through insurance. Grounded in science, Octave enables clients to experience profound change that is as measurable as it is meaningful.
- Alentis Therapeutics — Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases.
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more...Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Series C
- United States, The Netherlands, Switzerland
Portfolio highlights
- VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
- Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Health Care, Artificial Intelligence, Medical
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Austria
Portfolio highlights
- basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
- ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more...Investment focus
- Biotechnology, Health Care, Software
- Funding Round, Series B, Series A
- Belgium, United States, The Netherlands
Portfolio highlights
- Chainels — The tenant experience app for every property in your portfolio. Save time, gain insights and collaborate with your tenants all in one place.
- VoxelSensors — Novel sensor architecture designed for low latency and low power 3D perception.
- fruitcore robotics — fruitcore robotics is a robotic system that leverages intelligent software and innovative mechatronics.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Seed, Debt Financing
- United States, Israel, Denmark
Portfolio highlights
- Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
- RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
- Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Metsola Ventures
Show more...Investment focus
- Medical, mHealth, Health Care
- Series A
- Finland
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- Synoste Oy — Patient friendly and innovative solutions for correcting skeletal deformations.
Maki.vc is an early-stage venture capital firm partnering with deep tech & brand-driven startups obsessed with challenging category norms.
Show more...Investment focus
- Software, SaaS, E-Commerce
- Seed, Series A, Funding Round
- Finland, Germany, United Kingdom
Portfolio highlights
- Strise — Strise is signaling a new era of enterprise software and organizational change, transforming how companies work and empowering individual growth through knowledge. We believe in the AI-enabled financial institution without data silos where users and data are working together to solve even the most complex business problems.
- Databutton — Databutton is an online app builder that empowers the next generation of entrepreneurs and innovators. It enables anyone to create dynamic online apps in minutes by connecting to a growing array of sources, models, and integrations, or by utilizing their own datasets. 먹튀검증 https://muktts.net/
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- France, United States, United Kingdom
Portfolio highlights
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
- Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
- Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- Belgium, Germany, The Netherlands
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Scenic Biotech — We are pioneers in the discovery of genetic modifiers to enable the development of transformative therapeutics.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
IPF Partners is a alternative financing provider focused on the European healthcare sector. IPF invests directly in emerging, commercial-stage European pharma/biotech, medtech and diagnostics companies.
Show more...Investment focus
- Health Care, Medical, Hospital
- Series B, Series C, Funding Round
- Finland, United States, United Kingdom
Portfolio highlights
- Lumeon — Transform the patient experience and ensure that care teams always work at top-of-license with the leaders in care orchestration.
- Mendor — Mendor is a Finnish company, committed to the design, development and marketing of advanced diabetes management products. Mendor has launched a revolutionary, discreet, easy to use, portable all-in-one blood glucose meter and web-based software application for the daily management of diabetes. Mendor has designed its products together with usersand diabetes experts to address the needs of people with diabetes requiring regular blood glucose monitoring.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
Founded in 2009, Spintop Ventures is a venture capital firm backed by a network of successful tech entrepreneurs who have invested in Spintop alongside institutional investors, family offices and some of the most experienced private investors in early stage growth companies.
Show more...Investment focus
- Software, Information Technology, SaaS
- Seed, Funding Round, Series A
- Sweden, Finland, Denmark
Portfolio highlights
- IPRally — Improve your invalidity, patentability and FTO searches. Easy-to-use patent search web application, powered by unique AI knowledge graph technology.
- Elastisys — Elastisys provides fully-managed Kubernetes Platform as a Service, GDPR-ready on EU clouds with optional PostgreSQL, RabbitMQ, and Redis.
- EmbeDL — Efficient Deep Learning for Embedded Systems
We provide venture capital for companies with cutting-edge technology that solves key issues in the transition to a net zero emissions world.
Show more...Investment focus
- Manufacturing, Energy, Software
- Funding Round, Series B, Series A
- United States, Germany, Canada
Portfolio highlights
- sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
- Colibri Energy — Colibri Energy - Lithium Batteries produces battery solutions for GSE & Logistics to reduce costs of operations and provide sustainable alternatives.
- NanoGraf Corporation — SiNode Systems is a materials venture based out of Northwestern University that is commercializing a novel silicon based anode technology developed by research team led by Professor Harold Kung. SiNode aims to change the status quo of the industry by developing high performance anodes for Li-ion batteries.
Loudspring is a cleantech accelerator in the Nordic region, boasting several fast growing and high impact companies that solve global challenges. The portfolio companies are active in energy- and resource efficiency as well as decentralized renewable energy and are based in Finland, Sweden and Germany. The company management consists of companybuilders and investors who have been active within the cleantech space for over a decade.The company is listed on First North Finland under the ticker LOUD and on First North Stockholm under the ticker LOUDS.
Show more...Investment focus
- SaaS, Smart Building, Property Management
- Series A, Seed, Grant
- Finland, United States
Portfolio highlights
- Nuuka — Nuuka is a building SW scaleup from Finland. Nuuka specialises in diagnosing and optimising HVAC, energy systems, and indoor climate. The SaaS is optimal for large building portfolios, of new and old public and commercial buidlings, as it can be used with any BMS and HVAC system, IAQ sensor or energy meter. Nuuka improves indoor climate, energyefficiency, reduces operational cost and improves sustainability for real estate owners, developers, retail chains and whole cities. We use SW, AI and ML to transform and industry, and save the world one building at the time.
- Swap.com — Swap is an online consignment and thrift store shop high-quality secondhand clothes. Shop the best brands at up to 90% off.
- ResQ Club — ResQ Club is a Finnish company connecting sustainable restaurants, cafes, and grocery stores with consumers that appreciate eating affordable quality food. ResQ partners can drastically reduce their food waste with their proprietary location-based mobile and web service, as it enables consumers to find and rescue surplus food in their proximity.Every meal purchased via ResQ is one less meal thrown away, helping their urban communities to waste less and be more sustainable.They are on a mission to reduce food waste to zero at restaurants, cafes, and grocery stores. It's estimated that 10% of the already produced food in restaurants ends up in the trash instead of hungry mouths. On a global scale, this equals 11 million tons of food wasted every year.
J12 Ventures invests early in innovative companies in the Nordics.
Show more...Investment focus
- Software, Machine Learning, Artificial Intelligence
- Seed, Pre-Seed, Series A
- Sweden, Germany, Portugal
Portfolio highlights
- Treyd — Working capital for fast growing brands. Order Now, Pay Suppliers Later
- Ostrom — We make energy fair, smart and green - one flexible monthly plan with no hidden fees, digital-first and 100% renewable energy.
- MVision AI — MVision develops technology that improves the treatment of various types of cancer by using artificial intelligence and machine learning. The company has been built on the idea to be an impactful organisation by bringing AI assisted diagnosis and treatment to whoever needs it, especially in developing countries. This dramatically improves treatmentoutcome and saves money.The founding team consists of AI PhD’s, data platform architects and physicists with experience from companies such as Varian Medical Systems and GE healthcare.
Nordic Option is a private equity fund focusing its investments on growth companies. It provides capital investments in small and medium-sized growth companies that have already established themselves in Northern Finland. The fund's investment strategy includes the possibility to make up to 5 early-stage growth investments with one millioneuros.The firm's value of investments in portfolio companies is approximately EUR 10 million and the value of loans granted is approximately EUR 1 million.
Show more...Investment focus
- Software, Manufacturing, 3D Technology
- Funding Round, Seed, Series C
- Finland
Portfolio highlights
- Haltian — End-to-end IoT solutions and world-glass product design services from Haltian
- SensorFu — SensorFu detects new network leak paths before they are exploited. If you're required to operate isolated networking environments, SensorFu helps you to anwer question: is my network isolation working as intended? Leaks from isolated network segments can be a result of human error or malice, and they may violate security policies orcontractual obligations. SensorFu automates previously manual audit checks, and it empowers IT- and IT security ops to ensure continuous network, and network segment isolation that meets their mission specific policies and regulatory requirements. SensorFu Beacon is available as virtual appliance, software application and as hardware appliance.
- Brightplus — Brightplus is an innovative renewable materials manufacturing company from Finland. We specialise in design and development of new functional properties for industrial biomaterial solutions. We cater for industries like packaging, construction, cosmetics and consumer goods. Our expertise is based on developing solutions to multiple industries andproviding fast prototyping and full fit for customers’ production lines. Our deep chemical BrightBio® technology creates an optimal fit between coatings, barriers and plastic replacing materials to help you in raising your material functionality to the next level.
Microsize has been a pioneer in enhancing dissolution and bioavailability of APIs via particle size reduction using micronization technologies
Show more...Investment focus
- Pharmaceutical, Product Research
- Seed
- Finland
Portfolio highlights
- The Solubility Company — The Solubility Company is a trusted preclinical CRO providing physicochemical measurement services based on the proprietary SPA method.
Wellville is a 10-year national nonprofit project to achieve equitable wellbeing. We support the efforts of The Wellville 5: Five US communities.
Show more...Investment focus
- Software, Health Care, Medical
- Funding Round, Series B, Series A
- United States, Finland
Portfolio highlights
- Upbeat — Upbeat is a software-powered next-generation PR agency that focuses on media marketing for various companies. The company is a team of software engineers and PR professionals working together to bring the old-school PR industry to the modern world. Upbeat turns story ideas to into something presentable by connecting the best stories to the beststorytellers. They also manage email outreach and follow-ups and keep track of pitch's progress with real-time analytics and email updates. And, its software is also an avenue to monitor media opportunities on company's behalf.
- Trimian — Startup based in Menlo Park, focusing on mobile apps. The name comes from 'tri-simian', referring to the three wise monkeys.
- Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. With our plants in Europe, North America, South America, andAsia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, refillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
Show more...Investment focus
- Health Care, Medical Device
- Seed
- Finland
Portfolio highlights
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
The first mass-produced Volvo car rolled off the production line in Gothenburg in 1927. Since then, they have delivered a steady stream of cars equipped with world-leading innovations. Today, they are one of the most well-known and respected car brands in the world with sales in about 100 countries.Volvo Car Group (Volvo Cars) is owned byZhejiang Geely Holding (Geely Holding) of China. Volvo Cars formed part of the Swedish Volvo Group until 1999 when Ford Motor Company bought the company. In 2010, Geely Holding acquired Volvo Cars.They produce premium cars with the following body types: Sedans, Estates/Sportswagons, Cross Country vehicles, SUVs, and Convertibles. Their cars are characterized by intuitive, human-focused, functional Scandinavian design and good craftsmanship.Relative to the strength of the brand, Volvo Cars is a small producer with global sales reaching 421,951 cars in 2012. Their largest markets are the United States, Sweden, China, Germany, and the UK. Their corporate and brand strategy is ”Designed Around You” and puts people at the heart of everything they do.As a responsible company, they want to contribute to a more sustainable society. To ensure that they are in harmony with customers and society, they do their part by spearheading the development of sustainable mobility - from plug-in hybrids and all-electric cars to active cooperation in a partnership project on road trains.They are proud to continuously deliver world-first solutions; innovations that put people first, by saving and simplifying their lives. Volvo Cars was owned by AB Volvo until 1999 when it was acquired by the Ford Motor Company as part of its Premier Automotive Group. Geely Holding Group then acquired Volvo Cars from Ford in 2010.
Show more...Portfolio highlights
- Forciot — Forciot is a Finnish technology company that was born in December 2015 out of love for engineering challenges and sports. Group of leading wearable researchers from Tampere University of Technology and consumer electronics experts agreed to put their heart and passion into developing together unique innovation that would start a new era in wearablebusiness.They realized that world is lacking wearable technologies that could be part of products that people use every day, everywhere.Today there starts to be an overload of separate measurement gadgets offered for people to be carried around them to measure performance.Their vision is that in the future they do not need to carry separate performance wearable gadgets with us anymore while for example exercising. Instead, the measurement technology will be integrated directly into those sporting products, such as shoes or gloves, that they all are using when training anyway.They decided to start building this new era of wearables. On their view, most product manufacturer companies will also evidently become IOT-product manufacturers in the future. FORCIOT® with innovative solutions that are connected to internet, is the engineering partner for these companies to build the future IOT-products.For their business to business customers, they offer advanced and accurate REAL-TIME force, power, pressure, balance and weight measurement system that will take wearable world to the next level. They provide their customers the capability to utilize force related data that has not been available before.
- Polestar — Wir stellen Performance-Elektroautos her. Unser Ziel: eine bessere Zukunft durch Innovationen.
Heraeus, the technology group headquartered in Hanau, Germany, is a leading international family-owned portfolio company.
Show more...Investment focus
- Biotechnology, Manufacturing, Therapeutics
- Seed, Series A, Funding Round
- Germany, Finland, Switzerland
Portfolio highlights
- aiXscale Photonics — aiXscale Photonics provides unique ultra-high precision optical glass interposer solutions for the building of transceiver optical subassemblies and co-packaged optics that are dependable, low loss, and cost-effective. We meet the demands of today's and tomorrow's high-volume data and telecommunications applications.
- MimiX Biotherapeutics — mimiX Biotherapeutics. https://www.mimixbio.com/ CymatiX THE FIRST ACOUSTIC BIOPRINTER Create biological architectures with sound Sound Induced Morphogenesis (SIM) is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves.
- Smart Steel Technologies — Smart Steel Technologies provides ready-to-use software products for the optimization of the steel manufacturing process chain.
Midinvest Management is a Finnish private equity firm specialized in ownership arrangements for small- and medium-sized enterprises.
Show more...Investment focus
- Software, Information Technology, Internet
- Seed, Funding Round, Convertible Note
- Finland
Portfolio highlights
- Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
- Quosis — As of March 18, 2008, Quosis Oy was acquired by Proactum Oy. Quosis Oy operates as an open source software service company. It offers open-source based solutions and services, including portal solution for managing organization’s information and services; content management for gathering, sharing, saving, and producing information; businessprocess management for automating, monitoring, managing, and improving key processes; integration of information systems; and instant messaging for improving the organizational information exchange. The company also offers open source consultation and software development services. It serves the paper industry. The company was founded in 2004 and is headquartered in Jyvaskyla, Finland.
- Howspace — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
Alumni Ventures offers diversified venture portfolios to accredited investors into highly competitive deals that individuals typically do not have access to on their own.
Show more...Investment focus
- Software, Health Care, SaaS
- Series A, Funding Round, Series B
- United States, Finland, Singapore
Portfolio highlights
- Humu — Confidently achieve your most ambitious goals. Give everyone the personalized, step-by-step support they need to take the best route towards big, shared finish lines.
- Printify — Sell custom t-shirts, phone cases, and 800+ products with your designs printed on demand. We will handle printing and shipping to your customers.
- Cambium Carbon — Cambium Carbon is an early stage social enterprise start up focused on implementing systems-level natural climate solutions centered on reforestation and urban wood reuse.
Close your round
Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.
Find investors — It's Free!Join 21,000+ founders from: